 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2025 |
|
 |
|
MERCK, SANOFI ANIMAL HEALTH JOINT VENTURE DELAYED
Mar. 1, 2011
Source: Agri Marketing magazine
The Wall Street Journal reports that the joint venture animal health company Merck and Sanofi are planning to form continues to be under review by antitrust regulars and has been delayed.
Announced last spring, the firms originally expected the deal to close by this month.
The companies previously jointly owned Merial, but Merck divested its half to Sanofi to gain clearance to acquire Schering-Plough, including its animal health unit Intervet/Schering Plough.
The Journal reports that one area which may need to be divested is its poultry vaccine lines which have an estimated 75% market share in the U.S.
If approved, the joint venture will be named Merial-Intervet.
|
|
|
|
|
